MedTrace Logo

Efficacy of Topical Capsaicin Cream for Stable Angina

NCT01231750 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2015-06-25

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to test the hypothesis that application of topical capsaicin in patients with stable angina will result in improved exercise tolerance and reduced cardiac ischemia.

Conditions

  • Stable Angina

Interventions

DRUG

Capsaicin

0.1% topical cream,4cm spread over 8cm x 15cm area on skin, one time, 45 minutes prior to exercise

OTHER

Placebo cream

cream, 4cm spread over 8cm x 15cm area of skin

Sponsors & Collaborators

  • University of Cincinnati

    collaborator OTHER

  • Neal Weintraub

    lead OTHER

Principal Investigators

  • Faisal M Khan, MD · University of Cincinnati

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01231750 on ClinicalTrials.gov